Newly identified drug target in rheumatoid arthritis paves way for development of new therapies
University of Melbourne researchers have identified a protein involved in rheumatoid arthritis-induced inflammation that could lead to new drug treatments for people who do not respond to current therapies.
Aug 22, 2018
0
1